ArticleCancer medicine2023

The effectiveness of blinatumomab in clearing measurable residual disease in pediatric B-cell acute lymphoblastic leukemia patients detected by next-generation sequencing.

Min'er Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.